SCHEMBL760013

SCHEMBL760013

O=c1cc(-c2cccc(F)c2)c2ccc(CBr)cc2o1.O=c1oc2ccccc2cc1CBr

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
TDP1 Q9NUW8 3/20 0.43
MAOB P27338 3/20 0.39
CA12 O43570 3/20 0.38
CA9 Q16790 3/20 0.38
ALDH2 P05091 1/20 0.38
AKR1B1 P15121 1/20 0.38
MAOA P21397 1/20 0.38
HSD17B3 P37058 1/20 0.38
SORD Q00796 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 2/20 0.38
GAPDH P04406 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761453 0.87 CA9 (0.47) ALDH1A1HPGDMAOBCA12CA9
SCHEMBL27771665 0.78 CA12 (0.45) ALDH1A1HPGDMAOBCA12CA9
SCHEMBL9009049 0.76 CA9 (0.62) KDM4EALDH1A1HPGDMAOBCA12
SCHEMBL759047 0.76 CA12 (0.50) KDM4EALDH1A1HPGDTDP1MAOB
SCHEMBL4075975 0.74 ALOX5 (0.53) KDM4EALDH1A1HPGDMAOBCA12
SCHEMBL28187031 0.73 MAOB (0.49) ALDH1A1HPGDMAOBCA12CA9
SCHEMBL765821 0.72 MAOA (0.58) KDM4EALDH1A1HPGDMAOBCA12
SCHEMBL28068462 0.71 RAB9A (0.71) KDM4EALDH1A1HPGDMAOBMEN1
SCHEMBL14079715 0.70 CA12 (0.42) ALDH1A1HPGDMAOBCA12CA9
SCHEMBL759601 0.69 CA12 (0.64) KDM4EALDH1A1HPGDMAOBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118093-B1 [1,2,3]TRIAZOLYL SUBSTITUTED QUINOLINES AND COUMARINS AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK CANADA INC (CA) 2012-03-21 EP disclosed
US-7960409-B2 e.g. 4-(3-fluorophenyl)-7-({4-[1-hydroxy-1-(trifluoromethyl)propyl]-1H-1,2,3-triazol-1-yl}methyl)-2H-chromen-2-one; leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents MERCK SHARP & DOHME CORP. (US) 2011-06-14 US disclosed